2 enrolling by invitation. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 2 |
Follow Depressive Disorder: new trials by email Literature Review of Depressive Disorder trials Research Report on Depressive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects LY03021, placebo - Major Depressive Disorder | Phase 1 | Enrolling by invitation | Luye Pharma Group Ltd. | 98 | 2025-10-28 | 2026-01-27 |
| Nitrous Oxide- Suicidal Ideation Nitrous Oxide, Placebo gas - Major Depressive Disorder, Depression | Phase 1 | Enrolling by invitation | Washington University School of Medicine | 50 | 2018-10-30 | 2025-12-22 |
Depressive Disorder, Major (2) · Depression (1) · Mood Disorders (1) · Suicidal Ideation (1)
Mental Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Mood Disorders (1) · Self-Injurious Behavior (1) · Suicide (1)
Nitrous Oxide (1)
Luye Pharma Group Ltd. (1) · Washington University School of Medicine (1)
China (1) · United States (1)